Suppr超能文献

由粉末衍射数据确定的吲达帕胺晶体结构。

Crystal structure of indapamide determined from powered diffraction data.

作者信息

Smrkolj M, Meden A

机构信息

Krka, Pharmaceutical Factory, Novo mesto, Slovenia.

出版信息

Pharmazie. 2006 Dec;61(12):999-1004.

Abstract

Indapamide is used in the treatment of hypertension. In the European Pharmacopoeia it is specified that indapamide may contain up to 3 wt.% of water. On the basis of the results of thermal (TGA, DSC), DVS and X-ray powder diffraction analyses it has been supposed that this feature arises from the fact that indapamide exists in the form of a non-stoichiometric hydrate. The water molecules are only weakly and reversibly bound into the crystal structure. The major framework of the crystal structure, built of indapamide molecules, remains practically unchanged upon dehydration and/or hydration processes. In order to prove this hypothesis and understand the hydration-dehydration behavior, the as yet unknown crystal structure of indapamide needed to be determined. Since it was not possible to grow any adequate single crystals, we decided to solve the structure from laboratory X-ray powder diffraction data. The solved structure confirmed the hypothesis of weakly bound water in the voids between the indapamide molecules and also served as a basis to evaluate and explain the relative humidity dependence of the unit cell parameters of indapamide.

摘要

吲达帕胺用于治疗高血压。欧洲药典规定,吲达帕胺可能含有高达3%(重量)的水。基于热分析(热重分析、差示扫描量热法)、动态水分吸附和X射线粉末衍射分析的结果,推测该特性源于吲达帕胺以非化学计量水合物的形式存在。水分子仅以弱且可逆的方式结合到晶体结构中。由吲达帕胺分子构成的晶体结构的主要框架在脱水和/或水合过程中实际上保持不变。为了证明这一假设并了解水合-脱水行为,需要确定吲达帕胺尚未知晓的晶体结构。由于无法生长出任何合适的单晶,我们决定从实验室X射线粉末衍射数据解析该结构。解析出的结构证实了吲达帕胺分子间空隙中存在弱结合水的假设,也为评估和解释吲达帕胺晶胞参数对相对湿度的依赖性提供了依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验